Kristian Steen Frederiksen, MD, PhD, FEBN, Danish Dementia Research Centre, Rigshospitalet, Copenhagen, Denmark, outlines the recommendations included in the new European Academy of Neurology (EAN) guideline on medical management issues in dementia. Dr Frederiksen highlights that patients with dementia should be offered systematic, regular, pre-planned medical follow-up. Additionally, for the majority of patients with agitation/aggression, treatment with antipsychotics should be avoided, and where antipsychotics are considered, using an atypical antipsychotic is recommended over haloperidol. Lastly, Dr Frederiksen mentions the importance of managing vascular risk factors in dementia as prevention of cerebrovascular pathology may impact the progression of dementia. This interview was recorded during an online conference call with The Video Journal of Dementia (VJDementia).
